Compounds > chitosan
Page last updated: 2024-08-25

chitosan and galantamine

chitosan has been researched along with galantamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
ElGamal, SS; Farid, RM; Hanafy, AS; Helmy, MW1
Darwish, AS; Kamal, SM; Wahba, SM1
Mishra, DN; Singh, SK1
ElGamal, SS; Farid, RM; Hanafy, AS; Kandil, LS1

Other Studies

4 other study(ies) available for chitosan and galantamine

ArticleYear
Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.
    Drug delivery, 2016, Volume: 23, Issue:8

    Topics: Acetylcholinesterase; Administration, Intranasal; Alzheimer Disease; Animals; Brain; Chitosan; Drug Delivery Systems; Galantamine; Male; Nanoparticles; Neurons; Rats; Rats, Wistar

2016
Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model.
    Materials science & engineering. C, Materials for biological applications, 2016, Aug-01, Volume: 65

    Topics: Aluminum Chloride; Aluminum Compounds; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cerebral Cortex; Cerium; Chitosan; Chlorides; Disease Models, Animal; Drug Carriers; Durapatite; Dynamic Light Scattering; Female; Galantamine; Hippocampus; Nanocomposites; Ovariectomy; Rats; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2016
Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice.
    Current drug delivery, 2019, Volume: 16, Issue:1

    Topics: Acetylcholinesterase; Adhesiveness; Administration, Intranasal; Administration, Oral; Alzheimer Disease; Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Chitosan; Cholinesterase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Galantamine; Humans; Male; Maze Learning; Mice; Nanoparticles; Nasal Mucosa; Nootropic Agents; Piracetam; Scopolamine; Treatment Outcome

2019
Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect.
    Drug development and industrial pharmacy, 2021, Volume: 47, Issue:5

    Topics: Administration, Intranasal; Animals; Antioxidants; Chitosan; Galantamine; Male; Nanoparticles; Neuroprotection; Oxidative Stress; Rats; Rats, Wistar

2021